Source: Journal of thrombosis and thrombolysis. Unidade: FM
Subjects: COVID-19, TROMBOSE, COAGULAÇÃO SANGUÍNEA
ABNT
OKAZAKI, Erica et al. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity. Journal of thrombosis and thrombolysis, v. 57, n. 4, p. 721-729, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76839. Acesso em: 21 jan. 2025.APA
Okazaki, E., Barion, B. G., Rocha, T. R. F. da, Giacomo, G. D., Ho, Y. -L., Rothschild, C., et al. (2024). Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity. Journal of thrombosis and thrombolysis, 57( 4), 721-729. doi:10.1007/s11239-024-02961-8NLM
Okazaki E, Barion BG, Rocha TRF da, Giacomo GD, Ho Y-L, Rothschild C, Fatobene G, Moraes B del G de C, Stefanello B, Rocha VG. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity [Internet]. Journal of thrombosis and thrombolysis. 2024 ; 57( 4): 721-729.[citado 2025 jan. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76839Vancouver
Okazaki E, Barion BG, Rocha TRF da, Giacomo GD, Ho Y-L, Rothschild C, Fatobene G, Moraes B del G de C, Stefanello B, Rocha VG. Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity [Internet]. Journal of thrombosis and thrombolysis. 2024 ; 57( 4): 721-729.[citado 2025 jan. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76839